Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors

NCT00104091 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

DRUG: TP-38

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.